GP ADHD Prescribing in Australia

Yes. Since 1 December 2025, Queensland specialist GPs (those holding FRACGP or FACRRM fellowship) can initiate, modify, and continue psychostimulant prescriptions for adult patients aged 18+. No mandatory additional training is required — fellowship qualifies. Approximately 9,600 QLD GPs are eligible. Voluntary RACGP CPD modules are available for upskilling. For patients under 18, shared-care with a psychiatrist is required for initiation, though all doctors can continue existing paediatric prescriptions.

Yes, partially. Since 1 September 2025, over 800 NSW GPs trained as "continuation prescribers" can continue and adjust stimulant prescriptions via SafeScript NSW for patients aged 6+ with an existing diagnosis. Over 18,000 scripts have been filled under Stage 1. Stage 2 training — allowing GPs to independently diagnose and initiate prescriptions — commenced in March 2026, with the first trained GPs expected mid-to-late 2026. Training is funded by NSW Health.

Yes, in states where GP ADHD prescribing is live. Vyvanse (lisdexamfetamine) is a PBS-listed ADHD medication. In Queensland, specialist GPs can initiate Vyvanse prescriptions for adults since December 2025. In NSW, trained GPs can continue Vyvanse prescriptions started by a specialist since September 2025. In South Australia and Western Australia, trained GPs can also prescribe Vyvanse since early 2026. Non-stimulant alternatives like atomoxetine (Strattera) can be prescribed by GPs in all states.

Yes, in states with GP prescribing reforms. Dexamphetamine is a Schedule 8 stimulant used to treat ADHD. In Queensland (from December 2025), SA (from February 2026), and WA (from early 2026), trained GPs can prescribe dexamphetamine. In NSW, GPs can continue dexamphetamine prescriptions initiated by a specialist. Victoria is training GPs to prescribe by September 2026. Each state has its own monitoring requirements — QLD uses real-time prescription monitoring, WA uses ScriptCheckWA, and NSW uses SafeScript.

Yes — in Queensland, South Australia, and Western Australia, trained GPs can formally diagnose ADHD using DSM-5 criteria and initiate medication. In NSW, Stage 2 training for GP diagnosis commenced March 2026. In Victoria, GPs will be able to diagnose once the training programme is complete (target September 2026). In all states, GPs can conduct initial screening using validated tools like the ASRS-6 and refer for specialist assessment where needed.

Specialist ADHD assessment wait times in Australia range from 6 months to over 2 years depending on location. Melbourne and Perth often have the longest waits (6-18 months). GP prescribing reforms aim to reduce these delays — Queensland, SA, and WA now allow trained GPs to diagnose and prescribe directly. NSW continuation prescribing (Stage 1) has already benefited over 5,000 patients since September 2025.

Not in every state. In Queensland, SA, and WA, trained GPs can diagnose and prescribe ADHD stimulants without a psychiatrist referral. In NSW, GPs can continue specialist-initiated prescriptions (Stage 1 live since September 2025), with full GP initiation expected mid-late 2026. Victoria is training GPs to prescribe by September 2026. The ACT allows GP continuation prescribing under CHO approval. Only the NT and Tasmania still fully require specialist initiation.

Yes — as of April 2026, GPs can prescribe ADHD medication in most Australian states. Queensland specialist GPs can fully initiate since December 2025. South Australia GPs can independently diagnose and prescribe since February 2026. Western Australia has 65 trained GPs prescribing since early 2026. NSW has 800+ continuation prescribers since September 2025, with initiation training underway. Victoria is training 150 GPs to prescribe by September 2026. The ACT launched GP training in February 2026. Tasmania has committed to reforms. Only the NT has not announced changes. Non-stimulant medications like atomoxetine and guanfacine can be prescribed by GPs in all states.

Training requirements vary significantly by state. Queensland requires no additional training — FRACGP or FACRRM fellowship qualifies. South Australia requires two RACGP online modules plus a full-day in-person session. Western Australia requires RACGP online modules plus a mandatory 6-month co-management period with specialist mentorship. NSW Stage 1 requires an accredited training module, Stage 2 requires 3-6 months of training. Victoria is developing RACGP-accredited training for 150 GPs. The RACGP is the central training body across most states.

GPs diagnosing ADHD should use validated DSM-5 aligned assessment tools that systematically evaluate all diagnostic criteria: inattention, hyperactivity/impulsivity, childhood onset, functional impairment, and differential diagnosis. ClientForms provides a comprehensive Adult ADHD Assessment covering all DSM-5 criteria with auto-scoring and criterion grouping, plus a Child ADHD Assessment (ages 5-17) completed by parents. Comorbidity screening (GAD-7 for anxiety, PHQ-9 for depression, AQ-10 for autism) is also recommended as part of a thorough assessment.

ADHD medication (particularly stimulants like dexamphetamine, lisdexamfetamine, and methylphenidate) is regulated at both federal and state level in Australia. While PBS listing is federal, the authority to prescribe Schedule 8 stimulants is regulated by each state and territory individually. Queensland moved first (December 2025), followed by NSW (September 2025 for continuation), SA (February 2026), and WA (early 2026). Each jurisdiction has its own training requirements and regulatory frameworks — for example, WA requires a unique 6-month co-management period while QLD has no mandatory training at all.

It depends on the state and patient age. In Queensland, SA, and WA, trained GPs can independently prescribe for adults without a psychiatrist — but shared-care is required for children under 18 in QLD. In NSW Stage 1, a specialist must initiate the prescription before a GP can continue it. In Victoria (once live), GPs will be able to prescribe independently for patients aged 6+. Each state has different age thresholds: QLD 18+, SA 8+, WA 10+, NSW 6+.

A GP ADHD assessment is typically covered under Medicare (bulk-billed or with a gap payment of $40-$90), compared to a private psychiatrist assessment which costs $400-$800+ out-of-pocket. GP assessments may require longer appointments (30-60 minutes) which attract a higher Medicare item number. Using a validated digital assessment tool like ClientForms means patients complete the detailed questionnaire before the appointment, making the GP consultation more efficient.

Yes. ClientForms is designed for Australian clinicians with all data hosted in Australia (Sydney region), AES-256 encryption, and compliance with the Australian Privacy Principles. Assessment forms are DSM-5 aligned with auto-scoring and criterion grouping. The free tier includes 10 responses per month with no credit card required — enough for most GPs starting ADHD assessments.

Auto-scoring means patient responses are automatically calculated and grouped by DSM-5 diagnostic criteria — inattention symptoms, hyperactivity/impulsivity symptoms, onset age, functional impairment, and differential diagnosis. Instead of manually tallying responses across a multi-page form, you receive a structured criterion report showing which diagnostic criteria are met and which are not. This saves 15-30 minutes per assessment and reduces scoring errors.